Raytheon Awarded $108 M for SM-2 Production
Newsletter Subscription


Thursday, July 31, 2014


Raytheon Awarded $108 M for SM-2 Production

  • Funding will support continued production of all-up rounds

The U.S. Navy awarded Raytheon Company (NYSE: RTN) a $108 million contract for continued production of Standard Missile-2 all-up rounds, a majority of which will be sold to U.S. allies through foreign military sales. This award brings the total fiscal year 2011 contract value to more than $200 million.

"The U.S. Navy has committed to supporting SM-2 past 2035, and this contract award reflects our international partners' desire to maintain this key defensive asset in their inventories," said Michael Campisi, Raytheon Missile Systems' senior director for SM-2 and SM-6 production. "The SM-2 production line is open for all our allies' requirements, and there will be full mission support available throughout the lifecycle of this critical asset."


SM-2 is deployed by the U.S. and eight allied navies. The missile provides high- and low-altitude intercept capabilities and performance against advanced anti-ship missile threats.

"SM-2 has been the primary surface-to-air fleet-air defense weapon of choice for decades," said Campisi. "It's an extremely effective, relevant weapon that will continue to protect navies around the globe for many years to come."

About Standard Missile-2
SM-2 is the world's premier fleet-area air defense weapon, providing protection from a wide range of advanced threats.

  • SM-2 has been integrated with both Aegis and non-Aegis combat weapon systems.
  • The missile can be launched from the MK-41, MK-13 and MK-26 launchers.
  • SM-2 has an extensive flight test history of more than 2,500 successful flight tests.

Source : Raytheon Corporation (NYSE: RTN)

Published on ASDNews: Dec 17, 2012

 

Integrated Air & Missile Defence Asia 2014 Conference

Aug 20 - 21, 2014 - Kuala Lumpur, Malaysia

Register More info


ITAR/EAR Beyond the Basics Seminar

Oct 15 - 16, 2014 - Annapolis, United States

Register More info


© 2004-2014 • ASDNews • be the first to know • contact usterms & conditionsprivacy policyadvertisingfaqs